5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 28.55▲ | 28.58▲ | 28.67▲ | 27.48▲ | N/A |
MA10 | 28.60▲ | 28.58▲ | 28.35▲ | 25.82▲ | N/A |
MA20 | 28.69▲ | 28.34▲ | 28.01▲ | N/A | N/A |
MA50 | 28.29▲ | 27.41▲ | 25.84▲ | N/A | N/A |
MA100 | 28.24▲ | 25.68▲ | 25.30▲ | N/A | N/A |
MA200 | 27.26▲ | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.045▼ | -0.039▼ | -0.045▼ | N/A | N/A |
RSI | 53.328▲ | 59.169▲ | 63.606▲ | 67.740▲ | N/A |
STOCH | 38.573 | 53.627 | 69.266 | N/A | N/A |
WILL %R | -55.446 | -29.243 | -29.243 | -18.894▲ | N/A |
CCI | -38.986 | 49.721 | 64.309 | 120.191▲ | N/A |
▲ BREAK | $QTTB Price Breaks 10 Days High | Set Alert |
Monday, April 15, 2024 11:11 AM
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic ...
|
Monday, April 15, 2024 11:11 AM
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic ...
|
Thursday, April 11, 2024 09:55 AM
Oppenheimer started coverage of Q32 Bio (NASDAQ:QTTB) with an outperform rating, citing the market potential of the company’s lead drug asset, bempikibart. The investment bank said it sees significant ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
29/04/24 | 28.33 | 29.195 | 27.99 | 29.04 | 17,790 |
26/04/24 | 28.89 | 28.89 | 27.51 | 28.02 | 28,370 |
25/04/24 | 26.17 | 28.57 | 26.17 | 28.24 | 37,593 |
24/04/24 | 25.62 | 26.7675 | 24.9001 | 26.59 | 29,687 |
23/04/24 | 24.84 | 25.92 | 24.65 | 25.50 | 25,380 |
22/04/24 | 22.16 | 25.20 | 21.28 | 24.82 | 47,702 |
19/04/24 | 23.70 | 23.70 | 21.99 | 22.49 | 20,667 |
18/04/24 | 23.76 | 24.50 | 23.19 | 24.38 | 13,252 |
17/04/24 | 24.20 | 25.30 | 24.12 | 24.12 | 29,311 |
16/04/24 | 26.82 | 26.91 | 24.79 | 24.99 | 42,670 |
|
|
||||
|
|
||||
|
|